Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega 3 and Glimepiride in Type 2 Diabetes
NCT03917940Completed
- Sponsor
- Damanhour University
- Start
- Jan 2019
- Primary completion
- May 2020
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Damanhour University. Primary endpoints: Serum Irisin Concentration at 3 months and Serum Sirtuin-1 Concentration at 3 months. Started Jan 2019; status: completed.
Beyond the preview
Go deeper on NCT03917940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03917940.